Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of TRD303 for postoperative analgesia after inguinal hernia repair
CTR20243690Phase 2Active
- Sponsor
- Beijing Tide Pharmaceutical Co., Ltd.
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TRD303 in postoperative pain, sponsored by Beijing Tide Pharmaceutical Co., Ltd.. Started Oct 2024; status: active.
02
Drugs
TRD303
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20243690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243690.